Sunshine Lake Pharma Co., Ltd. Class H

As of December 31, 2025, Sunshine Lake Pharma Co., Ltd. Class H carries a market capitalization of 26.27B, placing it among publicly traded companies globally. Its enterprise value stands at 29.80B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of December 31, 2025, Sunshine Lake Pharma Co., Ltd. Class H has 576.18M shares outstanding.

These figures are as of December 31, 2025.

As of December 31, 2025, Sunshine Lake Pharma Co., Ltd. Class H maintains a current ratio of 0.77, meaning it holds 0.8x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended December 31, 2025.

As of the close on October 22, 2026, Sunshine Lake Pharma Co., Ltd. Class H's stock has declined approximately 12.75% over the past 52 weeks. The 50-day moving average sits at 38.84, while the 200-day moving average is 39.87.

As of December 31, 2025, Sunshine Lake Pharma Co., Ltd. Class H holds 1.67B in cash and equivalents against 5.21B in total debt, resulting in a net debt position of 2.87B. Total book value stands at 4.83B, with working capital of -1.54B providing operational flexibility.